Competition in human genetic technologies: The current US legal landscape

Here, we offer a perspective on the US legal landscape regarding the promotion of competition, with specific attention given to the human genetics and genomics industry. We highlight current policy on mergers, non-competition agreements, and exclusive dealings and use Illumina and Grail as a case study.